Circular RNA UVRAG (circUVRAG), a type of non-coding RNA, is derived and cyclized by part of the exon from the UVRAG gene. However, the role of circUVRAG in bladder cancer (BLCA) has not been reported. The purpose of the present study was therefore to characterize the role of circUVRAG in BLCA. Bioinformatics analysis showed interactive relationships among circUVRAG, microRNA-223 (miR-223), and fibroblast growth factor receptor 2 (FGFR2). Quantitative real-time PCR was used to detect the expression of circUVRAG in BLCA cell lines. UM-UC-3 cells were stably transfected with siRNA against circUVRAG, and cell proliferation and migration ability were tested using the CCK8 assay, clone formation, and Transwell assays in vitro.
| INTRODUC TI ON
Bladder cancer is a common malignant tumor of the urinary system. The 5-year prevalence of this disorder is increasing, ranking ninth in cancer incidence worldwide and 13th as a cause of death by cancer. 1, 2 Most chemotherapy clinical trials for advanced bladder carcinoma have shown poor prognoses. 3 To develop an effective treatment, it is therefore necessary to first identify the potential molecular targets and novel pathways underlying tumorigenesis and development of bladder cancer.
Circular RNA (circRNA) is a novel class of competitive endogenous RNAs formed by a covalently closed loop. 4, 5 Increasing evidence has shown that circRNAs are effective diagnostic biomarkers for some cancers. 6, 7 Previous studies reported that abnormal expressions of circRNAs were useful to determine the progress of BLCA, and high throughput sequencing found that hsa_circ_0023642 (circUVRAG) was significantly increased in BLCA. 8 However, the role of circUVRAG in the progression of BLCA is still unclear. Importantly, it has been reported that circRNAs could be targeted by endogenous miRNAs, to suppress miRNA activity, acting as miRNA sponges, 9 but the regulatory roles of circUVRAG, acting as "miRNA sponges" in BLCA, are still largely unknown.
The present study sought to examine the expression of circU-VRAG in BLCA, and then assess the biological roles of circUVRAG.
Our results showed that circUVRAG was upregulated in BLCA, and its upregulation remarkably promoted cell proliferation and migration. Our data provide novel evidence that could form the basis for the development of novel therapeutic strategies against bladder cancer.
| MATERIAL S AND ME THODS

| Animal ethics statement
Four-week-old BALB/c nude mice (n = 20) weighing 15-20 g (SLARC,
Shanghai, China) were used in this study. All animal experiments were approved by The Ethics Committee of Huashan Hospital, Fudan University, Shanghai, China. 
| Cell culture and transfection
| Fluorescence in situ hybridization
Specific probes to the circUVRAG sequence were used for in situ hybridization as previously reported. 10 In brief, FITClabelled probes were specific to circUVRAG. DAPI was used for cell nucleus counterstain. All procedures were conducted according to the manufacturer's protocol (Genepharma, Shanghai, China).
| Bioinformatics analysis
The circRNA/miRNA target gene was predicted using the website at https://circinteractome.nia.nih.gov/. The interactive relationship between miR-223 and FGFR2 was predicted using the website at http://www.targetscan.org/; the expression level of UVRAG and the prognoses in bladder cancer patients was predicted using the website at http://gepia.cancer-pku.cn/.
| Cell proliferation assay and cloning formation assay
Cell Counting Kit-8 assay was used to detect cell proliferation. The colonies were imaged and counted after they were fixed and stained.
| Western blots
Protein from cells and tumor tissues were extracted and concentrated using RIPA lysis buffer containing protease inhibitors Membranes were blocked with 5% nonfat dry milk for 2 hours before being incubated with primary antibodies at 4°C overnight.
GAPDH was used as the internal control. Membranes were then incubated with HRP-coupled secondary antibodies for 1 hour at room temperature.
| RNA extraction and quantitative RT-PCR
RNA extraction was carried out using TRIzol reagent (Invitrogen) as previously reported. 4 cDNA was obtained using a pTRUEscript 1st
Strand cDNA Synthesis Kit (Aidlab, Beijing, China). qRT-PCR was carried out using the 2× SYBR Green qPCR Mix (Aidlab) on an ABI 7900HT sequence detection machine (Thermo Fisher Scientific, Waltham, MA, USA). Expression fold changes were determined using the 2 −ΔΔCT method.
| Migration assay
Cell migration was measured using 24-well Transwell chambers (8 μm pore membrane; BD Biosciences, Franklin Lakes, NJ, USA).
A total of 1 × 10 5 cells were plated into the upper chamber with 200 μL serum-free medium while the bottom chamber was filled with 500 μL completed medium. After culturing for 24 hours, cells in the bottom chamber were fixed with 4% paraformaldehyde for 30 minutes, then stained with crystal violet for 10 minutes.
| Tumor xenograft formation and metastasis assays
A total of 2 × 10 7 viable cells from WT or sicircUVRAG UM-UC-3 cells were injected into the right flanks of nude mice as in our previous study. 11 Tumor sizes were measured every 5 days using a Vernier caliper, and the volume was calculated using the following formula: 
| Dual luciferase reporter assay
| Statistical analysis
Data are presented as mean ± standard deviation (SD). GraphPad
Prism software, version 5.0 (GraphPad, La Jolla, CA, USA) was used to compare group differences. P ≤ 0.05 indicated a statistically significant difference.
| RE SULTS
| Expression of circUVRAG was increased in BLCA cell lines
Previous studies using high-throughput microarray assays have verified that hsa_circ_0023642 (circUVRAG) was significantly increased in BLCA when compared with normal control samples. 8 The aim of the present study was therefore to confirm whether circUVRAG plays a role in the progress of BLCA. Hsa_circ_0023642 was derived and cyclized by part of the exon from the UVRAG gene. UVRAG is a UV radiation resistance-associated gene, and its expression increases sensitivity to chemotherapy by promoting autophagy. 12, 13 Bioinformatics analysis showed that high expression of UVRAG predicted a poor prognosis in bladder cancer patients ( Figure 1A) . We FISH assay showed that circUVRAG was predominately localized in the cytoplasm ( Figure 1C ). Taken together, the results suggested that circUVRAG played a role in the progression of BLCA.
| Downregulation of circUVRAG suppressed tumor formation and metastasis in nude mice xenografts
To further confirm that circUVRAG was involved in the progression of BLCA, lentiviral-stabilized circUVRAG silenced UM-UC-3 cells or a negative control (NC) were used for tumor formation. Results showed that the expression of circUVRAG was significantly decreased after silencing of circUVRAG (Figure 2A ) 
| Overexpression of FGFR2 reversed miR-223-induced UM-UC-3 cell growth and migration inhibition in vitro
To further confirm the relationship between FGFR2 and miR-223, analyzed and data are presented as mean ± SD. ***P < .001 vs NC. ### P < .001 vs sicircRNA. C, CCK-8 assays were carried out to assess cell proliferation. Data are presented as mean ± SD. ***P < .001 vs NC. D, Cloning formation assay showing cell proliferation of UM-UC-3. Data are presented as mean ± SD. *P < .05, ***P < .001 vs NC. ### P < .001 vs sicircRNA. E, Cell migration was determined in UM-UC-3 cells using Transwell assays. Data are presented as mean ± SD. *P < .05, ***P < .001 vs NC. ### P < .001 vs sicircRNA. GADPH (load control); NC, normal control; sicircUVRAG, small interfering circular RNA UVRAG suppressed cell migration. FGFR2 overexpression promoted migration of UM-UC-3 cells (Figure 4G,H) . Taken together, the results suggested that miR-223 expression suppressed tumor cell proliferation and metastasis by suppressing FGFR2 expression.
| Interactive relationships among miR-223, circUVRAG, and FGFR2
To confirm the relationships among miR-223, circUVRAG, and FGFR2, bioinformatics analyses showed that circUVRAG targeted miR-223. To further determine whether miR-223 was a possible target of circUVRAG, a luciferase reporter analysis was used to
show that miR-223 was a downstream binding target of circUVRAG ( Figure 5A ). Taken together, the results showed that circUVRAG inhibited luciferase activity in WT cells but did not affect the activity in mutated cell lines ( Figure 5B ).
To further identify whether FGFR2 was a possible target of miR-223, bioinformatics analysis was used to confirm that miR-222 directed interactions with the 3′-UTR of FGFR2 and suppressed FGFR2 expression at the mRNA level ( Figure 5C ). Luciferase reporter analysis found that miR-223 inhibited luciferase activity in WT cells, but not in mutated cell lines ( Figure 5D ). The results suggested that silencing circUVRAG inhibited bladder cancer metastasis and growth by targeting the miR-223/FGFR2 axis.
| D ISCUSS I ON
Studies have shown that the expression profiles of non-coding RNAs, including miRNAs and long non-coding RNAs (lncRNAs), are abnormal in many types of cancers, and these studies have focused on epigenetic regulation in cancer development. 14, 15 Recent studies have reported that many miRNAs and some lncRNAs may serve as regulators in BLCA development. 16, 17 However, whether circRNAs play a role in BLCA is unknown.
In this study, we found that circUVRAG was abnormally expressed in BLCA cell lines. Downregulation of circUVRAG suppressed cell proliferation and migration in both in vivo and in vitro experiments. Recent studies have reported that UVRAG not only promotes Beclin-1-mediated autophagy, but it also facilitates endosome/autophagosome maturation. 18, 19 Activation of autophagy can increase chemo-and radiotherapy resistance in bladder cancer. [20] [21] [22] We also found that high expression of UVRAG predicted poor prognosis, which was consistent with the role of circUVRAG.
Results also showed that miR-223 and FGFR2 were involved in the regulation of BLCA cell proliferation and migration. Previous Relative protein levels (C) were analyzed and data are presented as mean ± SD. ***P < .001 vs NC. ### P < .001 vs mimic. D, CCK-8 assays were carried out to assess cell proliferation. Data are presented as mean ± SD. ***P < .001. # P < .05 vs mimic. E,F, Cloning formation assay showing cell proliferation of UM-UC-3. Data are presented as mean ± SD. ***P < .001. ### P < .001 vs mimic. G,H, Cell migration and invasion were determined in UM-UC-3 cells using Transwell assays. Data are presented as mean ± SD. ***P < .001 vs NC. # P < .05 vs mimic. NC, normal control studies have reported that miR-223 acts as a suppressor and as a potential therapeutic target for glioblastoma, 23 colorectal cancer, 24 lung cancer, 25 colon adenocarcinoma, 26 and bladder cancer. 27 In the present study, we also found that downregulation of circUVRAG promoted miR-223 expression. Bioinformatics analysis found that circUVRAG interacted with several miRNAs including miR-507, miR-508, and miR-653, but miR-223 has more conservative binding sites. 
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